Gatifloxacin hydroxy acid impurity is a fluoroquinolone derivative characterized by a substituted quinolone core bearing a hydroxyl group at the 8-position and a carboxylic acid moiety at the 3-position. It features two fluorine atoms at C-6 and C-8, a cyclopropylmethyl group at C-1, and a piperazin-1-yl substituent at N-7. This impurity arises from oxidative degradation of the parent drug's methoxy group, introducing a hydroxyl functionality. Its structural similarity to gatifloxacin enables use as an HPLC reference standard for impurity profiling in active pharmaceutical ingredient (API) quality control.
On RequestC1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)O)F)F)C(=O)O
InChI=1S/C13H9F2NO4/c14-8-3-6-10(12(18)9(8)15)16(5-1-2-5)4-7(11(6)17)13(19)20/h3-5,18H,1-2H2,(H,19,20)
NTWOKQCCNHKEIU-UHFFFAOYSA-N